Skip to main content

GARLAND CAPITAL MANAGEMENT INC

Location
BELLEVUE, WA
Portfolio Value
Micro $831,274
Diversification
Diversified
Filing Date
Global Rank
#7,720 / 7,976 ▼ 734
Top Industry
Drug Manufacturers - General 23.1%
3Y Alpha vs SPY
-4.1%
Period ended 9 months ago
Filed Nov 5, 2025 · 7mo
23 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+59.2%
SPY
+76.3%
Annualised alpha
-4.1%
Max drawdown
−14.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

18 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
9.0%
+1.2 pts
Top 5
39.2%
+8.6 pts
Top 10
67.3%
+13.6 pts
HHI
606
Dec 2022 → Sep 2025 · range 368 – 606
Diversified+157

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 27.4% $1,817,181
Financial Services 22.2% $1,475,148
Real Estate 13.1% $871,141
Technology 12.5% $831,274
Consumer Defensive 10.6% $702,801
Industrials 7.1% $468,524
Utilities 3.8% $250,875
Energy 3.3% $218,182

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
No qualifying positions this quarter.

Trimmed

Positions the filer reduced
17 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
No qualifying positions this quarter.

Sold Out

Positions the filer fully exited
7 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
2 positions · $831,274 total · Technology only · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History